These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 931552)

  • 1. Production of antibodies against ML antigen in the xenogeneic host.
    Radzikowski C; Zak-Nejmark T; Wysocka M; Steuden J
    Arch Immunol Ther Exp (Warsz); 1977; 25(4):507-13. PubMed ID: 931552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. II. Increased expression of tumor-associated antigens on subline cells recognized by serologic and transplantation methods.
    Fuji H; Mihich E; Pressman D
    J Natl Cancer Inst; 1979 Jun; 62(6):1503-10. PubMed ID: 286122
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen.
    Raychaudhuri S; Saeki Y; Fuji H; Kohler H
    J Immunol; 1986 Sep; 137(5):1743-9. PubMed ID: 3018080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
    Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y
    Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity.
    Eck SC; Turka LA
    Cancer Res; 2001 Apr; 61(7):3077-83. PubMed ID: 11306490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
    Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
    Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antilymphocyte globulin for leukemia induction in mice.
    Radzikowski C; Szkudlarek J; Czarnomska A; Steuden J; Krajewski L
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):697-711. PubMed ID: 793567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-thymocyte autoimmunity in BALB/C mice accompanying immunization to a syngeneic lymphoma.
    Baechtel FS; Prager MD
    J Immunol; 1977 Jan; 118(1):175-9. PubMed ID: 299754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enhancement of the immune response following immunization with L1210 cells preliminarily incubated with interferon].
    Skurkovich SV; Kalinina IA; Eremkina EI; Bulycheva TI
    Biull Eksp Biol Med; 1976 Jun; 81(6):706-7. PubMed ID: 953308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common leukemia-associated antigen of DBA/2 mouse leukemia detected by tumor rejection and complement-dependent cytotoxicity assays.
    Kawashima K; Takeyama H; Takahashi T; Kato Y; Watanabe E; Suzuki H; Minam S; Isobe K; Yamada K; Ito Y
    Gan; 1979 Dec; 70(6):769-76. PubMed ID: 94022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper cells active in the generation of cytotoxicity to a syngeneic tumor.
    Hancock EJ; Kilburn DG; Levy JG
    J Immunol; 1981 Oct; 127(4):1394-7. PubMed ID: 6168688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the idiotypic network in tumor immunity.
    Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
    J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE
    Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of sera obtained by hyperimmunizing rabbits with interferon from mouse L cells.
    Kisielow B; Inglot AD; Chudzio T
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):37-44. PubMed ID: 444043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.